Hagop Youssoufian

2012 - ZIOPHARM Oncology

In 2012, Hagop Youssoufian earned a total compensation of $1.3M as President of Research and Development and Chief Medical Officer at ZIOPHARM Oncology, a 31% decrease compared to previous year.

Compensation breakdown

Bonus$278,750
Option Awards$525,564
Salary$450,000
Other$52,545
Total$1,306,859

Youssoufian received $525.6K in option awards, accounting for 40% of the total pay in 2012.

Youssoufian also received $278.8K in bonus, $450K in salary and $52.5K in other compensation.

Rankings

In 2012, Hagop Youssoufian's compensation ranked 5,088th out of 11,487 executives tracked by ExecPay. In other words, Youssoufian earned more than 55.7% of executives.

ClassificationRankingPercentile
All
5,088
out of 11,487
56th
Division
Manufacturing
1,778
out of 4,253
58th
Major group
Chemicals And Allied Products
427
out of 1,198
64th
Industry group
Drugs
278
out of 920
70th
Industry
Pharmaceutical Preparations
219
out of 700
69th
Source: SEC filing on April 30, 2014.

Youssoufian's colleagues

We found four more compensation records of executives who worked with Hagop Youssoufian at ZIOPHARM Oncology in 2012.

2012

Jonathan Lewis

ZIOPHARM Oncology

Chief Executive Officer

2012

Jason Amello

ZIOPHARM Oncology

Chief Financial Officer

2012

Caesar Belbel

ZIOPHARM Oncology

Chief Legal Officer

2012

Richard Bagley

ZIOPHARM Oncology

Chief Financial Officer

You may also like